(LIND) Lindblad Expeditions - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5352191093
Stock: Expedition Travel, Ship Tours, Land Tours, Cycling Tours
Total Rating 52
Risk 62
Buy Signal -0.82
| Risk 5d forecast | |
|---|---|
| Volatility | 49.4% |
| Relative Tail Risk | -12.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 31.48 |
| Character TTM | |
|---|---|
| Beta | 1.244 |
| Beta Downside | 2.473 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.01% |
| CAGR/Max DD | 0.49 |
EPS (Earnings per Share)
Revenue
Description: LIND Lindblad Expeditions March 05, 2026
Lindblad Expeditions Holdings, Inc. (LIND) offers marine expedition adventures and land-based travel experiences globally.
The Lindblad segment focuses on ship-based expeditions to remote and culturally significant locations, utilizing specialized vessels for close-up exploration. This segment operates in a niche within the cruise industry, emphasizing experiential travel over traditional cruising.
The Land Experiences segment provides over 100 itineraries in more than 45 countries, including eco-conscious expeditions, nature tours, and small-group cycling adventures. This diversified approach helps mitigate risks associated with reliance on a single travel mode.
LIND partners with organizations like National Geographic and the World Wildlife Fund, integrating expert-led experiences and conservation themes into its offerings. Investors can find detailed financial analysis and performance metrics for LIND on ValueRay.
Headlines to watch out for
- Global travel demand impacts expedition bookings
- Fuel price fluctuations influence operating costs
- Geopolitical events disrupt remote travel itineraries
- Regulatory changes affect international maritime operations
- Partnership strength with National Geographic drives brand value
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -29.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.01 > 1.0 |
| NWC/Revenue: -12.15% < 20% (prev -17.69%; Δ 5.53% < -1%) |
| CFO/TA 0.13 > 3% & CFO 123.4m > Net Income -29.7m |
| Net Debt (407.1m) to EBITDA (86.3m): 4.72 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.3m) vs 12m ago 1.72% < -2% |
| Gross Margin: 37.64% > 18% (prev 0.44%; Δ 3.72k% > 0.5%) |
| Asset Turnover: 83.05% > 50% (prev 73.52%; Δ 9.52% > 0%) |
| Interest Coverage Ratio: 0.52 > 6 (EBITDA TTM 86.3m / Interest Expense TTM 45.2m) |
Altman Z'' -2.21
| A: -0.10 (Total Current Assets 367.9m - Total Current Liabilities 461.6m) / Total Assets 980.0m |
| B: -0.42 (Retained Earnings -411.4m / Total Assets 980.0m) |
| C: 0.03 (EBIT TTM 23.5m / Avg Total Assets 928.4m) |
| D: -0.36 (Book Value of Equity -411.4m / Total Liabilities 1.13b) |
| Altman-Z'' Score: -2.21 = D |
Beneish M
| DSRI: none (Receivables none/none, Revenue 771.0m/644.7m) |
| GMI: 1.16 (GM 37.64% / 43.78%) |
| AQI: 1.01 (AQ_t 0.09 / AQ_t-1 0.09) |
| SGI: 1.20 (Revenue 771.0m / 644.7m) |
| TATA: -0.16 (NI -29.7m - CFO 123.4m) / TA 980.0m) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of LIND shares?
As of March 16, 2026, the stock is trading at USD 16.16 with a total of 833,148 shares traded.
Over the past week, the price has changed by -9.26%, over one month by -21.32%, over three months by +13.48% and over the past year by +58.59%.
Over the past week, the price has changed by -9.26%, over one month by -21.32%, over three months by +13.48% and over the past year by +58.59%.
Is LIND a buy, sell or hold?
Lindblad Expeditions has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy LIND.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LIND price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.5 | 39.2% |
| Analysts Target Price | 22.5 | 39.2% |
LIND Fundamental Data Overview March 16, 2026
P/E Forward = 19.2308
P/S = 1.3676
P/B = 159.797
Revenue TTM = 771.0m USD
EBIT TTM = 23.5m USD
EBITDA TTM = 86.3m USD
Long Term Debt = 662.7m USD (from longTermDebt, last quarter)
Short Term Debt = 1.15m USD (from shortTermDebt, last quarter)
Debt = 663.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 407.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.46b USD (1.05b + Debt 663.8m - CCE 256.7m)
Interest Coverage Ratio = 0.52 (Ebit TTM 23.5m / Interest Expense TTM 45.2m)
EV/FCF = 19.33x (Enterprise Value 1.46b / FCF TTM 75.6m)
FCF Yield = 5.17% (FCF TTM 75.6m / Enterprise Value 1.46b)
FCF Margin = 9.81% (FCF TTM 75.6m / Revenue TTM 771.0m)
Net Margin = -3.85% (Net Income TTM -29.7m / Revenue TTM 771.0m)
Gross Margin = 37.64% ((Revenue TTM 771.0m - Cost of Revenue TTM 480.8m) / Revenue TTM)
Gross Margin QoQ = 14.13% (prev 42.00%)
Tobins Q-Ratio = 1.49 (Enterprise Value 1.46b / Total Assets 980.0m)
Interest Expense / Debt = 1.62% (Interest Expense 10.7m / Debt 663.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = 18.5m (EBIT 23.5m * (1 - 21.00%))
Current Ratio = 0.80 (Total Current Assets 367.9m / Total Current Liabilities 461.6m)
Debt / Equity = -3.30 (negative equity) (Debt 663.8m / totalStockholderEquity, last quarter -201.4m)
Debt / EBITDA = 4.72 (Net Debt 407.1m / EBITDA 86.3m)
Debt / FCF = 5.38 (Net Debt 407.1m / FCF TTM 75.6m)
Total Stockholder Equity = -223.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.20% (Net Income -29.7m / Total Assets 980.0m)
RoE = 13.32% (negative equity) (Net Income TTM -29.7m / Total Stockholder Equity -223.1m)
RoCE = 5.34% (EBIT 23.5m / Capital Employed (Equity -223.1m + L.T.Debt 662.7m))
RoIC = 4.87% (NOPAT 18.5m / Invested Capital 380.7m)
WACC = 6.94% (E(1.05b)/V(1.72b) * Re(10.50%) + D(663.8m)/V(1.72b) * Rd(1.62%) * (1-Tc(0.21)))
Discount Rate = 10.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.82%
[DCF] Terminal Value 75.72% ; FCFF base≈68.9m ; Y1≈46.1m ; Y5≈21.8m
[DCF] Fair Price = 1.81 (EV 525.4m - Net Debt 407.1m = Equity 118.2m / Shares 65.3m; r=6.94% [WACC]; 5y FCF grow -38.64% → 2.90% )
EPS Correlation: 49.57 | EPS CAGR: 98.10% | SUE: -0.34 | # QB: 0
Revenue Correlation: 79.29 | Revenue CAGR: 30.33% | SUE: 1.60 | # QB: 6
EPS next Quarter (2026-06-30): EPS=-0.07 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.17 | Chg7d=+0.099 | Chg30d=-0.107 | Revisions Net=+0 | Growth EPS=+432.3% | Growth Revenue=+8.3%
EPS next Year (2027-12-31): EPS=0.30 | Chg7d=+0.000 | Chg30d=-0.100 | Revisions Net=+1 | Growth EPS=+72.0% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
P/S = 1.3676
P/B = 159.797
Revenue TTM = 771.0m USD
EBIT TTM = 23.5m USD
EBITDA TTM = 86.3m USD
Long Term Debt = 662.7m USD (from longTermDebt, last quarter)
Short Term Debt = 1.15m USD (from shortTermDebt, last quarter)
Debt = 663.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 407.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.46b USD (1.05b + Debt 663.8m - CCE 256.7m)
Interest Coverage Ratio = 0.52 (Ebit TTM 23.5m / Interest Expense TTM 45.2m)
EV/FCF = 19.33x (Enterprise Value 1.46b / FCF TTM 75.6m)
FCF Yield = 5.17% (FCF TTM 75.6m / Enterprise Value 1.46b)
FCF Margin = 9.81% (FCF TTM 75.6m / Revenue TTM 771.0m)
Net Margin = -3.85% (Net Income TTM -29.7m / Revenue TTM 771.0m)
Gross Margin = 37.64% ((Revenue TTM 771.0m - Cost of Revenue TTM 480.8m) / Revenue TTM)
Gross Margin QoQ = 14.13% (prev 42.00%)
Tobins Q-Ratio = 1.49 (Enterprise Value 1.46b / Total Assets 980.0m)
Interest Expense / Debt = 1.62% (Interest Expense 10.7m / Debt 663.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = 18.5m (EBIT 23.5m * (1 - 21.00%))
Current Ratio = 0.80 (Total Current Assets 367.9m / Total Current Liabilities 461.6m)
Debt / Equity = -3.30 (negative equity) (Debt 663.8m / totalStockholderEquity, last quarter -201.4m)
Debt / EBITDA = 4.72 (Net Debt 407.1m / EBITDA 86.3m)
Debt / FCF = 5.38 (Net Debt 407.1m / FCF TTM 75.6m)
Total Stockholder Equity = -223.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.20% (Net Income -29.7m / Total Assets 980.0m)
RoE = 13.32% (negative equity) (Net Income TTM -29.7m / Total Stockholder Equity -223.1m)
RoCE = 5.34% (EBIT 23.5m / Capital Employed (Equity -223.1m + L.T.Debt 662.7m))
RoIC = 4.87% (NOPAT 18.5m / Invested Capital 380.7m)
WACC = 6.94% (E(1.05b)/V(1.72b) * Re(10.50%) + D(663.8m)/V(1.72b) * Rd(1.62%) * (1-Tc(0.21)))
Discount Rate = 10.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.82%
[DCF] Terminal Value 75.72% ; FCFF base≈68.9m ; Y1≈46.1m ; Y5≈21.8m
[DCF] Fair Price = 1.81 (EV 525.4m - Net Debt 407.1m = Equity 118.2m / Shares 65.3m; r=6.94% [WACC]; 5y FCF grow -38.64% → 2.90% )
EPS Correlation: 49.57 | EPS CAGR: 98.10% | SUE: -0.34 | # QB: 0
Revenue Correlation: 79.29 | Revenue CAGR: 30.33% | SUE: 1.60 | # QB: 6
EPS next Quarter (2026-06-30): EPS=-0.07 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.17 | Chg7d=+0.099 | Chg30d=-0.107 | Revisions Net=+0 | Growth EPS=+432.3% | Growth Revenue=+8.3%
EPS next Year (2027-12-31): EPS=0.30 | Chg7d=+0.000 | Chg30d=-0.100 | Revisions Net=+1 | Growth EPS=+72.0% | Growth Revenue=+6.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)